- ¥49bn
- ¥44bn
- ¥874m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.69 | ||
| Price to Tang. Book | 7.69 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 54.74 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -23.9% | ||
| Return on Equity | -22.49% | ||
| Operating Margin | -174.47% | ||
Financial Summary
| Year End 31st Oct | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | n/a | n/a | 499.06 | 344.73 | 873.61 | n/a | n/a | 32.31% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Heartseed Inc is a Japan-based company engaged in research and development of regenerative medicine products. The Company has established cardiac regenerative medicine, a therapy in which microtissue (cardiomyocytes) derived from iPS cells are transplanted into the heart, and conducts business activities for patients with severe heart failure. Target diseases include dilated cardiomyopathy (DCM), old myocardial infarction (OMI), and dilated-phase hypertrophic cardiomyopathy (D-HCM). Except the pipeline's leading cardiac treatment HS-001 (administration of regenerated myocardium derived from allogeneic iPS cells to the myocardium), the Company also conducts research into the creation of myocardium using autologous iPS cells that do not pose immune rejection reactions and iPS cells with HLA knockout.
Directors
- Last Annual
- October 31st, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- November 30th, 2015
- Public Since
- July 30th, 2024
- No. of Shareholders
- 6,565
- No. of Employees
- 39
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange- Shares in Issue
- 22,513,400
- Address
- 5F, Seavans South Bldg., 1-2-3, Shibaura, MINATO-KU, 105-0023
- Web
- https://heartseed.jp/
- Phone
- +81 363801068
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 219A
Similar to 219A
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
As of Today at 21:03 UTC, shares in Heartseed are trading at ¥2,124. This share price information is delayed by 15 minutes.
Shares in Heartseed last closed at ¥2,124 and the price had moved by over the past 365 days. In terms of relative price strength the Heartseed share price has matched the Nikkei 225 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreHeartseed does not currently pay a dividend.
Heartseed does not currently pay a dividend.
Heartseed does not currently pay a dividend.
To buy shares in Heartseed you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥2,124, shares in Heartseed had a market capitalisation of ¥49bn.
Here are the trading details for Heartseed:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 219A
Based on an overall assessment of its quality, value and momentum Heartseed is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Heartseed. Over the past six months, its share price has outperformed the Nikkei 225 Index by +83.72%.
As of the last closing price of ¥2,124, shares in Heartseed were trading +15.45% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Heartseed PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥2,124.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Heartseed's directors